ニュース

"It's not just taking something away, but really doing a careful assessment of how that medication works within that ...
CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...
CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...
Prior authorization varies by plan but often requires patients or their providers to get permission (also called ...
CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...
CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...
Over a median follow-up of 7 years, breast cancer survivors had an 8% lower risk of Alzheimer's dementia compared with ...
The FDA approved dupilumab (Dupixent) as the first targeted drug for bullous pemphigoid, a rare blistering skin disease that ...
Manav Midha is an MD candidate at the Icahn School of Medicine at Mount Sinai and a researcher at the USC Schaeffer Center ...
Wade, Medicaid expansion, marijuana decriminalization, and the rights of same-sex couples prior to Obergefell v. Hodges. Now, ...
An often cited example of the importance of including a wide sample of patients is research showing that certain drugs can be ...